The role of testosterone in the pathogenesis of prostate cancer
Authors:
- 19 May 2008
- journal article
- review article
- Published by Wiley in International Journal of Urology
- Vol. 15 (6) , 472-480
Abstract
Abstract: Relationships between androgenic hormones and prostatic tissue growth are complex. It is certainly true that the prostate will not develop without androgens and the gland will atrophy if androgen support is withdrawn. The hormonal hypothesis remains one of the most important hypotheses in the etiology of prostate cancer (PCa), and efforts are continuing to improve the understanding of androgen actions in PCa. Although evidence from epidemiological studies of associations between circulating levels of androgens and PCa risk has been inconsistent, the traditional view that higher testosterone (T) levels represent a risk factor for PCa appears to have little evidentiary support. Reinvestigation of the relationship between T and PCa seems important and necessary if a new, clinically and scientifically rewarding concept is to be constructed. The present review considers the metabolism and intraprostatic action of T, epidemiological evidence, and the association between T and PCa risk.Keywords
This publication has 97 references indexed in Scilit:
- Estrogens and aspects of prostate diseaseInternational Journal of Urology, 2006
- Testosterone and Prostate Cancer: An Historical Perspective on a Modern MythEuropean Urology, 2006
- Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone TherapyCancer Epidemiology, Biomarkers & Prevention, 2005
- Elevated Expression of Inhibin α in Prostate CancerJournal of Urology, 2004
- High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective studyInternational Journal of Cancer, 2003
- Effect of Nonsteroidal Anti-Inflammatory Agents and Finasteride on Prostate Cancer RiskJournal of Urology, 2002
- Hormones and prostate cancer: Current perspectives and future directionsThe Prostate, 2002
- The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young MenThe Journal of Clinical Endocrinology & Metabolism, 2002
- TestosteroneDrugs & Aging, 2000
- Longitudinal evaluation of serum androgen levels in men with and without prostate cancerThe Prostate, 1995